WEST PHARMACEUTICAL SERVICES, INC. Capital Expenditures
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Capital Expenditures of $85.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $43.20M, a 42.55% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $42.70M, a 40.11% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $76.10M, a 27.45% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $63.30M, a 22.14% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $285.90M, a 24.16% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $377.00M, a 4.14% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $362.00M, a 27.20% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $284.60M, a 12.31% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $43.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $85.90M 10-Q · filed 2026-07-23 | $162.00M derived: sum of 3 quarters · filed 2026-07-23 | $225.30M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $42.70M 10-Q · filed 2026-04-23 | $118.80M derived: sum of 2 quarters · filed 2026-04-23 | $182.10M derived: sum of 3 quarters · filed 2026-04-23 | $257.30M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $76.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $139.40M derived: sum of 2 quarters · filed 2026-02-17 | $214.60M derived: sum of 3 quarters · filed 2026-07-23 | $285.90M 10-K · filed 2026-02-17 |
| 2025-09-30 | $63.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $138.50M derived: sum of 2 quarters · filed 2026-07-23 | $209.80M 10-Q · filed 2025-10-23 | $314.70M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $75.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $146.50M 10-Q · filed 2026-07-23 | $251.40M derived: sum of 3 quarters · filed 2026-07-23 | $332.70M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $71.30M 10-Q · filed 2026-04-23 | $176.20M derived: sum of 2 quarters · filed 2026-04-23 | $257.50M derived: sum of 3 quarters · filed 2026-04-23 | $357.70M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $104.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $186.20M derived: sum of 2 quarters · filed 2026-02-17 | $286.40M derived: sum of 3 quarters · filed 2026-02-17 | $377.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $81.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $181.50M derived: sum of 2 quarters · filed 2025-10-23 | $272.10M 10-Q · filed 2025-10-23 | $380.80M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $100.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $190.80M 10-Q · filed 2025-07-24 | $299.50M derived: sum of 3 quarters · filed 2026-02-17 | $395.30M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $90.60M 10-Q · filed 2025-04-24 | $199.30M derived: sum of 2 quarters · filed 2026-02-17 | $295.10M derived: sum of 3 quarters · filed 2026-02-17 | $370.50M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $108.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $204.50M derived: sum of 2 quarters · filed 2026-02-17 | $279.90M derived: sum of 3 quarters · filed 2026-02-17 | $362.00M 10-K · filed 2026-02-17 |
| 2023-09-30 | $95.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $171.20M derived: sum of 2 quarters · filed 2024-10-24 | $253.30M 10-Q · filed 2024-10-24 | $348.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $75.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $157.50M 10-Q · filed 2024-07-25 | $252.40M derived: sum of 3 quarters · filed 2025-02-18 | $310.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $82.10M 10-Q · filed 2024-04-25 | $177.00M derived: sum of 2 quarters · filed 2025-02-18 | $234.80M derived: sum of 3 quarters · filed 2025-02-18 | $300.90M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $94.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $152.70M derived: sum of 2 quarters · filed 2025-02-18 | $218.80M derived: sum of 3 quarters · filed 2025-02-18 | $284.60M 10-K · filed 2025-02-18 |
| 2022-09-30 | $57.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $123.90M derived: sum of 2 quarters · filed 2023-10-26 | $189.70M 10-Q · filed 2023-10-26 | $266.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $66.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $131.90M 10-Q · filed 2023-07-27 | $208.40M derived: sum of 3 quarters · filed 2024-02-20 | $273.70M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $65.80M 10-Q · filed 2023-04-27 | $142.30M derived: sum of 2 quarters · filed 2024-02-20 | $207.60M derived: sum of 3 quarters · filed 2024-02-20 | $264.50M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $76.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $141.80M derived: sum of 2 quarters · filed 2024-02-20 | $198.70M derived: sum of 3 quarters · filed 2024-02-20 | $253.40M 10-K · filed 2024-02-20 |
| 2021-09-30 | $65.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $122.20M derived: sum of 2 quarters · filed 2022-10-27 | $176.90M 10-Q · filed 2022-10-27 | $234.60M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $56.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $111.60M 10-Q · filed 2022-07-28 | $169.30M derived: sum of 3 quarters · filed 2023-02-21 | $216.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $54.70M 10-Q · filed 2022-04-28 | $112.40M derived: sum of 2 quarters · filed 2023-02-21 | $159.90M derived: sum of 3 quarters · filed 2023-02-21 | $197.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $57.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $105.20M derived: sum of 2 quarters · filed 2023-02-21 | $142.30M derived: sum of 3 quarters · filed 2023-02-21 | $174.40M 10-K · filed 2023-02-21 |
| 2020-09-30 | $47.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $84.60M derived: sum of 2 quarters · filed 2021-10-28 | $116.70M 10-Q · filed 2021-10-28 | $154.30M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $37.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $69.20M 10-Q · filed 2021-07-30 | $106.80M derived: sum of 3 quarters · filed 2022-02-22 | $138.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $32.10M 10-Q · filed 2021-04-30 | $69.70M derived: sum of 2 quarters · filed 2022-02-22 | $101.40M derived: sum of 3 quarters · filed 2022-02-22 | $129.70M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $69.30M derived: sum of 2 quarters · filed 2022-02-22 | $97.60M derived: sum of 3 quarters · filed 2022-02-22 | $126.40M 10-K · filed 2022-02-22 |
| 2019-09-30 | $31.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $60.00M derived: sum of 2 quarters · filed 2020-10-23 | $88.80M 10-Q · filed 2020-10-23 | $118.80M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $28.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $57.10M 10-Q · filed 2020-07-24 | $87.10M derived: sum of 3 quarters · filed 2021-02-23 | $113.60M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $28.80M 10-Q · filed 2020-04-24 | $58.80M derived: sum of 2 quarters · filed 2021-02-23 | $85.30M derived: sum of 3 quarters · filed 2021-02-23 | $105.50M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $56.50M derived: sum of 2 quarters · filed 2021-02-23 | $76.70M derived: sum of 3 quarters · filed 2021-02-23 | $104.70M 10-K · filed 2021-02-23 |
| 2018-09-30 | $26.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $46.70M derived: sum of 2 quarters · filed 2019-10-29 | $74.70M 10-Q · filed 2019-10-29 | $104.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $20.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $48.20M 10-Q · filed 2019-07-29 | $77.70M derived: sum of 3 quarters · filed 2020-02-24 | $112.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $28.00M 10-Q · filed 2019-05-08 | $57.50M derived: sum of 2 quarters · filed 2020-02-24 | $91.80M derived: sum of 3 quarters · filed 2020-02-24 | $121.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $29.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $63.80M derived: sum of 2 quarters · filed 2020-02-24 | $93.30M derived: sum of 3 quarters · filed 2020-02-24 | $130.80M 10-K · filed 2020-02-24 |
| 2017-09-30 | $34.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $63.80M derived: sum of 2 quarters · filed 2018-10-30 | $101.30M 10-Q · filed 2018-10-30 | $148.80M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $29.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $67.00M 10-Q · filed 2018-07-31 | $114.50M derived: sum of 3 quarters · filed 2019-02-28 | $163.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $37.50M 10-Q · filed 2018-05-08 | $85.00M derived: sum of 2 quarters · filed 2019-02-28 | $133.70M derived: sum of 3 quarters · filed 2019-02-28 | $168.70M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $47.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $96.20M derived: sum of 2 quarters · filed 2019-02-28 | $131.20M derived: sum of 3 quarters · filed 2019-02-28 | $170.20M 10-K · filed 2019-02-28 |
| 2016-09-30 | $48.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $83.70M derived: sum of 2 quarters · filed 2017-10-31 | $122.70M 10-Q · filed 2017-10-31 | $167.50M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $35.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $74.00M 10-Q · filed 2017-08-01 | $118.80M derived: sum of 3 quarters · filed 2018-02-26 | $148.50M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $39.00M 10-Q · filed 2017-05-05 | $83.80M derived: sum of 2 quarters · filed 2018-02-26 | $113.50M derived: sum of 3 quarters · filed 2018-02-26 | $140.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $44.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $74.50M derived: sum of 2 quarters · filed 2018-02-26 | $101.20M derived: sum of 3 quarters · filed 2018-02-26 | $131.60M 10-K · filed 2018-02-26 |
| 2015-09-30 | $29.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $56.40M derived: sum of 2 quarters · filed 2016-10-31 | $86.80M 10-Q · filed 2016-10-31 | $113.90M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $26.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $57.10M 10-Q · filed 2016-08-01 | $84.20M derived: sum of 3 quarters · filed 2017-02-28 | $112.80M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $30.40M 10-Q · filed 2016-05-06 | $57.50M derived: sum of 2 quarters · filed 2017-02-28 | $86.10M derived: sum of 3 quarters · filed 2017-02-28 | $110.60M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $27.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $55.70M derived: sum of 2 quarters · filed 2017-02-28 | $80.20M derived: sum of 3 quarters · filed 2017-02-28 | $111.90M 10-K · filed 2017-02-28 |
| 2014-09-30 | $28.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $53.10M derived: sum of 2 quarters · filed 2015-11-02 | $84.80M 10-Q · filed 2015-11-02 | $123.60M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $24.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $56.20M 10-Q · filed 2015-08-03 | $95.00M derived: sum of 3 quarters · filed 2016-02-26 | $124.30M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $31.70M 10-Q · filed 2015-05-06 | $70.50M derived: sum of 2 quarters · filed 2016-02-26 | $99.80M derived: sum of 3 quarters · filed 2016-02-26 | $121.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $38.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $68.10M derived: sum of 2 quarters · filed 2016-02-26 | $90.20M derived: sum of 3 quarters · filed 2016-02-26 | $151.90M 10-K · filed 2016-02-26 |
| 2013-09-30 | $29.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $51.40M derived: sum of 2 quarters · filed 2014-11-03 | $113.10M 10-Q · filed 2014-11-03 | $146.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $22.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $83.80M 10-Q · filed 2014-08-01 | $116.70M derived: sum of 3 quarters · filed 2015-02-25 | $145.70M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $61.70M 10-Q · filed 2014-05-08 | $94.60M derived: sum of 2 quarters · filed 2015-02-25 | $123.60M derived: sum of 3 quarters · filed 2015-02-25 | $160.60M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $32.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $61.90M derived: sum of 2 quarters · filed 2015-02-25 | $98.90M derived: sum of 3 quarters · filed 2015-02-25 | $131.30M 10-K · filed 2015-02-25 |
| 2012-09-30 | $29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $66.00M derived: sum of 2 quarters · filed 2013-11-04 | $98.40M 10-Q · filed 2013-11-04 | $131.80M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $69.40M 10-Q · filed 2013-08-05 | $102.80M derived: sum of 3 quarters · filed 2014-02-27 | $127.00M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $32.40M 10-Q · filed 2013-05-06 | $65.80M derived: sum of 2 quarters · filed 2014-02-27 | $90.00M derived: sum of 3 quarters · filed 2014-02-27 | $108.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $57.60M derived: sum of 2 quarters · filed 2014-02-27 | $76.00M derived: sum of 3 quarters · filed 2014-02-27 | $95.40M 10-K · filed 2014-02-27 |
| 2011-09-30 | $24.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $42.60M derived: sum of 2 quarters · filed 2012-11-05 | $62.00M 10-Q · filed 2012-11-05 | $83.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $18.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $37.80M 10-Q · filed 2012-08-06 | $59.10M derived: sum of 3 quarters · filed 2013-02-27 | $76.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $19.40M 10-Q · filed 2012-05-04 | $40.70M derived: sum of 2 quarters · filed 2013-02-27 | $57.90M derived: sum of 3 quarters · filed 2013-02-27 | $72.80M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $38.50M derived: sum of 2 quarters · filed 2013-02-27 | $53.40M derived: sum of 3 quarters · filed 2013-02-27 | $71.10M 10-K · filed 2013-02-27 |
| 2010-09-30 | $17.20M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $32.10M derived: sum of 2 quarters · filed 2011-11-07 | $49.80M 10-Q · filed 2011-11-07 | $78.30M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-06-30 | $14.90M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $32.60M 10-Q/A · filed 2011-08-08 | $61.10M derived: sum of 3 quarters · filed 2012-03-01 | $88.70M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-03-31 | $17.70M 10-Q · filed 2011-05-05 | $46.20M derived: sum of 2 quarters · filed 2012-03-01 | $73.80M derived: sum of 3 quarters · filed 2012-03-01 | |
| 2009-12-31 | $28.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $56.10M derived: sum of 2 quarters · filed 2012-03-01 | $104.90M 10-K/A · filed 2012-03-01 | |
| 2009-09-30 | $27.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $76.40M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $48.80M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $138.60M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |